---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-075008"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2024-09-03T23:59:59+00:00"
generated_at: "2026-05-31T06:39:45.559398+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Onconetix faces Nasdaq delisting risk; must meet initial listing criteria including $4.00 minimum bid price

## Summary
- Nasdaq ruled Proteomedix AG acquisition triggers Change of Control; must satisfy initial listing rules including $4.00 minimum bid price.
- Company has until Sept 16, 2024 to regain Bid Price Rule compliance ($1.00 close for 10 days); extension for stockholders' equity runs to Nov 4, 2024.
- Board proposes reverse stock split (1-for-30 to 1-for-60) to boost per-share price and meet Nasdaq minimum price and equity requirements.
- Failure to comply could lead to delisting; common stock would trade OTC, materially reducing liquidity and capital access.

## SEC filing metadata
- accession: 0001213900-24-075008
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2024-09-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390024075008/0001213900-24-075008-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390024075008/ea0213181-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-075008
- JSON: https://secwatch.observer/filing/0001213900-24-075008.json
- Plain text: https://secwatch.observer/filing/0001213900-24-075008.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.